Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0002064832-25-000065

Chief Medical Officer sold 798 shares at $14.23 ($11,356)

From the SEC's structured data for this filing

Trades in this filing

Rottinghaus Scott T. · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-12-05 Sale : show line 1 in the form −798 $14.23 $11,356 21,792 D
Open-market sales · 798 sh · avg $14.23 · $11,356
Loading xslF345X05/form4.xml…